天津医药 ›› 2016, Vol. 44 ›› Issue (4): 413-417.doi: 10.11958/20150371

• 专题研究-乳腺肿瘤 • 上一篇    下一篇

肿瘤微环境对乳腺癌发生发展的影响

汪玲1 , 赵鹏飞2 , 吕一品1 , 郭静艺1 , 孙鸣1 , 吴慧哲2 , 魏敏杰2?   

  1. 1沈阳,中国医科大学(邮编110122); 2中国医科大学药学院
  • 收稿日期:2015-12-03 修回日期:2016-03-08 出版日期:2016-04-15 发布日期:2016-05-20
  • 通讯作者: ∆通讯作者 E-mail: feipeng8865@163.com E-mail:feipeng8865@163.com
  • 基金资助:
    2014年辽宁省大学生创新创业训练项目 (2014020); 2015辽宁省大学生创新创业训练项目 (201510159000053)

The effects of tumor microenvironment on the development and progression of breast cancer

WANG Ling1 , ZHAO Pengfei 2 , LYU Yipin1 , GUO Jingyi 1 , SUN Ming1 , WU Huizhe2 , WEI Minjie2?   

  1. 1 China Medical University, Shenyang 110122, China; 2 Shcool of Pharmacy, China Medical University
  • Received:2015-12-03 Revised:2016-03-08 Published:2016-04-15 Online:2016-05-20
  • Contact: △Corresponding Author E-mail:feipeng8865@163.com E-mail:feipeng8865@163.com

摘要: 摘要: 肿瘤微环境 (TME) 在局部耐药性、 免疫逃脱和远端转移等多个肿瘤发生、 发展的步骤中起关键作用。依据 不同个体的 TME, 准确评估和选择临床用药, 可有效控制原位癌和转移癌的恶性转化。目前, 治疗癌症的主要方法 是化疗, 由于 TME 中良性细胞可调节癌细胞对标准化疗和靶向药物治疗的反应, 因此, 结合靶向 TME 治疗会取得更 理想的临床疗效。本文就乳腺癌 TME 中细胞外基质 (ECM)、 肿瘤相关成纤维细胞、 肿瘤相关巨噬细胞、 调节性 T 细 胞和骨髓间质干细胞对肿瘤发生、 发展的作用机制进行综述。

关键词: 肿瘤微环境, 乳腺癌, 细胞外基质, 肿瘤相关成纤维细胞, 肿瘤相关巨噬细胞, 调节性T 细胞, 骨髓间质干细胞

Abstract: Abstract: Tumor microenvironment (TME) plays a key role in the development and progression of tumors, such as pro⁃ moting local drug resistance, immune escape, and distal metastasis. According to the TME of different individuals, accurate evaluation and selection of clinical medication can effectively control the malignant transformation of carcinoma in situ and metastatic cancer. At present, the main method to treat cancer is chemotherapy, TME can regulate the reaction of the tumor cells to the standard chemotherapy and target drug therapy, so the combination of the targeted TME therapy and chemothera⁃ py will achieve better clinical efficacy. In this review, we summarized the mechanisms of TME in breast cancer, including ex⁃ tracellular matrix, carcinoma-associated fibroblasts, carcinoma-associated macrophages, regulatory T cells and bone marrow mesenchymal stem cells, which providing a theoretical basis for the development of TME targeted therapy.

Key words: tumor microenvironment, breast cancer, extracellular matrix, carcinoma-associated fibroblasts, carcinoma- associated macrophages, regulatory T cells, bone marrow mesenchymal stem cells